Sie sind hier: Startseite > Therapeutics (ehemalig) > Editorial

J Cannabis Ther 2004(1):1-6

Editorial

Editorial

Author
E. Russo

Abstract

The Journal of Cannabis Therapeutics is proud to initiate its fourth year of publication with this issue, but regrets that it will be its last, as explained below.

In this final issue, we are pleased to present additional data on cannabinoid delivery and harm reduction. Dale Gieringer et al. present the first scientific analysis of results obtained with the Volcano®, a cannabis vaporizer device. The success of such technologies may address a key recommendation of the U.S. Institute of Medicine in its emphasis on non-smoked cannabis delivery systems.

Franjo Grotenhermen provides another extensive review article, this time on cannabinoid pharmacodynamics, to complement his previous offerings on cannabinoid pharmacokinetics.

Tod Mikuriya documents his extensive clinical experience in use of cannabis in treating alcoholism, an indication first claimed in the 19th century. Although sure to be controversial, this concept is one that deserves additional study considering the compelling public health issues and considerable cost to society. New approaches employing cannabinoid mechanisms may prove fruitful in providing alternatives to current treatment of this disorder

PDF des gesamten Artikels ]

Veranstaltungen 2020

Alle Informationen zu den IACM Online Events inklusive kostenlose Videos der Webinare mit deutschen Untertiteln finden Sie hier.

IACM-Konferenz 2021

Die 12. IACM-Konferenz zur Cannabinoide in der Medizin wird vom 14. bis 16. Oktober 2021 online stattfinden. Die Registrierung ist kostenlos.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.